NicolaeLecaMD

Nephrology • Seattle, WA

Professor of Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Leca is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leca's full profile

Already have an account?

Office
PO Box
# 1959
Seattle, WA 98195
Phone+1 206-598-5068

Fax+1 206-598-8740

Education & Training

University at BuffaloFellowship, Nephrology, 2002 - 2004
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1999 - 2002
Carol Davila University of Medicine and PharmacyClass of 1997

Certifications & Licensure

AK State Medical License 2023 - 2026
WA State Medical License 2005 - 2026
MT State Medical License 2023 - 2025
ID State Medical License 2023 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Clinical Trials

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients Start of enrollment: 2019 Oct 14
Terminated
Phase 3
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx Start of enrollment: 2021 Oct 14
Recruiting
Phase 3
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

49 citations
Initial Skin Cancer Screening for Solid Organ Transplant Recipients in the United States: Delphi Method Development of Expert Consensus Guidelines
Lauren D. Crow, Anokhi Jambusaria-Pahlajani, Christina L. Chung, David A. Baran, Stefan E. Lowenstein
Transplant International. 2019-12-01
71 citations
Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort.
Anna E. Coghill, Lisa G. Johnson, Daniel Berg, Alexa J. Resler, Nicolae Leca
American Journal of Transplantation. 2016-02-01
43 citations
Conversion from Calcineurin Inhibitor to Belatacept-based Maintenance Immunosuppression in Renal Transplant Recipients: a Randomized Phase 3b Trial.
Klemens Budde, Rohini Prashar, Hermann Haller, M Rial, Nassim Kamar
Journal of the American Society of Nephrology. 2021-10-27